| 25 Jul 2025 | 08:00:00 | Cancellation - Indivior PLC |
| 25 Jul 2025 | 07:00:01 | Indivior Announces Completion of London Delisting |
| 24 Jul 2025 | 15:52:08 | Holding(s) in Company |
| 24 Jul 2025 | 08:34:14 | Holding(s) in Company |
| 23 Jul 2025 | 08:08:26 | Holding(s) in Company |
| 17 Mar 2025 | Annual Report and Accounts 2024 (ESEF Version) | |
| 14 Mar 2024 | Indivior PLC Annual Report and Accounts 2023 (ESEF Version) | |
| 13 Mar 2024 | Annual Report and Accounts for year ended 31 December, 2023. |
Indivior is a multinational pharmaceutical corporation dedicated to improving the lives of patients by developing innovative treatments for substance use disorders and other severe mental illnesses.
| 25 Jul 2025 | 08:00:00 | Cancellation - Indivior PLC |
| 25 Jul 2025 | 07:00:01 | Indivior Announces Completion of London Delisting |
| 24 Jul 2025 | 15:52:08 | Holding(s) in Company |
| 24 Jul 2025 | 08:34:14 | Holding(s) in Company |
| 23 Jul 2025 | 08:08:26 | Holding(s) in Company |
| 17 Mar 2025 | Annual Report and Accounts 2024 (ESEF Version) | |
| 14 Mar 2024 | Indivior PLC Annual Report and Accounts 2023 (ESEF Version) | |
| 13 Mar 2024 | Annual Report and Accounts for year ended 31 December, 2023. |
Indivior is a multinational pharmaceutical corporation dedicated to improving the lives of patients by developing innovative treatments for substance use disorders and other severe mental illnesses.